Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Angiogenesis Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Angiogenesis Inhibitorsmarket, defines the market attractiveness level of Cancer Angiogenesis Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Angiogenesis Inhibitors industry, describes the types of Cancer Angiogenesis Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Angiogenesis Inhibitors market and the development prospects and opportunities of Cancer Angiogenesis Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Angiogenesis Inhibitors market in Chapter 13.
By Player:
Marsala Biotech
Five Prime Therapeutics
Mabtech
Kyowa Hakko Kirin
ImClone Systems
Levolta Pharmaceuticals
Fuji Film Kyowa Kirin Biologics
Intas Pharmaceuticals
Novartis
Hetero Drugs
Genentech
Genexine
Neumedicines
By Type:
VEGF Targeted Therapy
FGF Targeted Therapies
Oncogene Targeted Therapy
Matrix Degrading & Remodeling Targeted Therapy
Others
By End-User:
Cancer
Interferon Alpha-2α
Ocular Neovascularization
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Angiogenesis Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Angiogenesis Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Angiogenesis Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Angiogenesis Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Angiogenesis Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.2 United States Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.3 Europe Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.4 China Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.5 Japan Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.6 India Cancer Angiogenesis Inhibitors Consumption (2017-2022)
-
7.7 South Korea Cancer Angiogenesis Inhibitors Consumption (2017-2022)
8 Region and Country-wise Cancer Angiogenesis Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Angiogenesis Inhibitors Consumption Forecast (2022-2028)
9 Global Cancer Angiogenesis Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Angiogenesis Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global VEGF Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global FGF Targeted Therapies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Oncogene Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Matrix Degrading & Remodeling Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Angiogenesis Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Interferon Alpha-2α Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ocular Neovascularization Consumption and Growth Rate (2017-2022)
10 Global Cancer Angiogenesis Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global VEGF Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global FGF Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Oncogene Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Matrix Degrading & Remodeling Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Interferon Alpha-2α Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ocular Neovascularization Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Angiogenesis Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Angiogenesis Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Angiogenesis Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Angiogenesis Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Angiogenesis Inhibitors Market Competitive Analysis
-
14.1 Marsala Biotech
-
14.1.1 Marsala Biotech Company Details
-
14.1.2 Marsala Biotech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Marsala Biotech Cancer Angiogenesis Inhibitors Product and Service
-
14.2 Five Prime Therapeutics
-
14.2.1 Five Prime Therapeutics Company Details
-
14.2.2 Five Prime Therapeutics Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Five Prime Therapeutics Cancer Angiogenesis Inhibitors Product and Service
-
14.3 Mabtech
-
14.3.1 Mabtech Company Details
-
14.3.2 Mabtech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mabtech Cancer Angiogenesis Inhibitors Product and Service
-
14.4 Kyowa Hakko Kirin
-
14.4.1 Kyowa Hakko Kirin Company Details
-
14.4.2 Kyowa Hakko Kirin Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kyowa Hakko Kirin Cancer Angiogenesis Inhibitors Product and Service
-
14.5 ImClone Systems
-
14.5.1 ImClone Systems Company Details
-
14.5.2 ImClone Systems Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ImClone Systems Cancer Angiogenesis Inhibitors Product and Service
-
14.6 Levolta Pharmaceuticals
-
14.6.1 Levolta Pharmaceuticals Company Details
-
14.6.2 Levolta Pharmaceuticals Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Levolta Pharmaceuticals Cancer Angiogenesis Inhibitors Product and Service
-
14.7 Fuji Film Kyowa Kirin Biologics
-
14.7.1 Fuji Film Kyowa Kirin Biologics Company Details
-
14.7.2 Fuji Film Kyowa Kirin Biologics Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Fuji Film Kyowa Kirin Biologics Cancer Angiogenesis Inhibitors Product and Service
-
14.8 Intas Pharmaceuticals
-
14.8.1 Intas Pharmaceuticals Company Details
-
14.8.2 Intas Pharmaceuticals Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Intas Pharmaceuticals Cancer Angiogenesis Inhibitors Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Cancer Angiogenesis Inhibitors Product and Service
-
14.10 Hetero Drugs
-
14.10.1 Hetero Drugs Company Details
-
14.10.2 Hetero Drugs Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Hetero Drugs Cancer Angiogenesis Inhibitors Product and Service
-
14.11 Genentech
-
14.11.1 Genentech Company Details
-
14.11.2 Genentech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Genentech Cancer Angiogenesis Inhibitors Product and Service
-
14.12 Genexine
-
14.12.1 Genexine Company Details
-
14.12.2 Genexine Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Genexine Cancer Angiogenesis Inhibitors Product and Service
-
14.13 Neumedicines
-
14.13.1 Neumedicines Company Details
-
14.13.2 Neumedicines Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Neumedicines Cancer Angiogenesis Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Angiogenesis Inhibitors
-
Figure Cancer Angiogenesis Inhibitors Picture
-
Table Global Cancer Angiogenesis Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Angiogenesis Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Angiogenesis Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Angiogenesis Inhibitors Consumption by Country (2017-2022)
-
Figure United States Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Angiogenesis Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VEGF Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global FGF Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Oncogene Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Matrix Degrading & Remodeling Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Alpha-2α Consumption and Growth Rate (2017-2022)
-
Figure Global Ocular Neovascularization Consumption and Growth Rate (2017-2022)
-
Figure Global VEGF Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FGF Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncogene Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Matrix Degrading & Remodeling Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Alpha-2α Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ocular Neovascularization Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Angiogenesis Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Angiogenesis Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Marsala Biotech (Foundation Year, Company Profile and etc.)
-
Table Marsala Biotech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marsala Biotech Cancer Angiogenesis Inhibitors Product and Service
-
Table Five Prime Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Five Prime Therapeutics Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Five Prime Therapeutics Cancer Angiogenesis Inhibitors Product and Service
-
Table Mabtech (Foundation Year, Company Profile and etc.)
-
Table Mabtech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mabtech Cancer Angiogenesis Inhibitors Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Cancer Angiogenesis Inhibitors Product and Service
-
Table ImClone Systems (Foundation Year, Company Profile and etc.)
-
Table ImClone Systems Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImClone Systems Cancer Angiogenesis Inhibitors Product and Service
-
Table Levolta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Levolta Pharmaceuticals Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Levolta Pharmaceuticals Cancer Angiogenesis Inhibitors Product and Service
-
Table Fuji Film Kyowa Kirin Biologics (Foundation Year, Company Profile and etc.)
-
Table Fuji Film Kyowa Kirin Biologics Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fuji Film Kyowa Kirin Biologics Cancer Angiogenesis Inhibitors Product and Service
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Cancer Angiogenesis Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Angiogenesis Inhibitors Product and Service
-
Table Hetero Drugs (Foundation Year, Company Profile and etc.)
-
Table Hetero Drugs Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drugs Cancer Angiogenesis Inhibitors Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Cancer Angiogenesis Inhibitors Product and Service
-
Table Genexine (Foundation Year, Company Profile and etc.)
-
Table Genexine Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genexine Cancer Angiogenesis Inhibitors Product and Service
-
Table Neumedicines (Foundation Year, Company Profile and etc.)
-
Table Neumedicines Cancer Angiogenesis Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neumedicines Cancer Angiogenesis Inhibitors Product and Service
-
